Penn Medicine Provider
Obstetrics and Gynecology
Andrea H. Roe, MD, MPH
4.9
(131)
Accepting new patients
Sees patients age 15 to 65
Penn Health for Women Washington Square
View 1 additional location
Make an appointmentCall 800-789-7366

About me

  • Assistant Professor of Obstetrics and Gynecology at the Pennsylvania Hospital

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

131 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

March 2025
2.0
2.0
i asked for further clarification on what i'm going through i felt like another blood test would've been helpful to see if there was an increase or decrease
March 2025
5.0
5.0
she made a really hard day a little easier with her care.
March 2025
5.0
5.0
explained options thoroughly and related it to their experience
January 2025
5.0
5.0
kind and comforting

Insurance accepted

My Locations

Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Roe is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Chin J, Sarkar M, Magaret A, Hsu C, Walker P, Schwind E, Taylor-Cousar J, Ladores-Barrett S, Hadjiliadis D, Roe AH, Godfrey E Liver function among women with cystic fibrosis who use hormonal contraception , European Congress on Menopause and Andropause: 2025

Creinin MD, Gawron LM, Roe AH, Blumenthal PD, Boraas CM, Hou MY, McNicholas C, Schreifels MJ, Peters K, Culwell K, Turok DK; Copper 175mm(2) IUD Phase 3 Clinical Investigator Group Three-year efficacy, safety, and tolerability outcomes from a phase 3 study of a low-dose copper intrauterine device. , Contraception, 143:110771: 2025

Wu J, Bochenek V, Gollomp K, Roe AH C-reactive protein and the menstrual cycle in females with sickle cell disease , Blood Vessels, Thrombosis, and Hemostasis: 2025

Lee IT, Wu J, Koelper N, Mumford SL, Barnhart KT, Roe AH Prediction of menstrual cycle phase using cross-sectional measurements of reproductive hormones. , Fertil Steril, 123(3):532-533: 2025

Jain R, Peng G, Lee M, Keller A, Cosmich S, Reddy S, West NE, Kazmerski TM, Goralski JL, Flume PA, Roe AH, Hadjiliadis D, Uluer A, Mody S, Ladores S, Taylor-Cousar JL. Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy , Chest, 167(2):348-361: 2025

Godfrey EM, Magaret A, Roe A, Taylor-Cousar JL, Walker P, Langfelder-Schwind E, Kazmerski TM, Jain R, Mody SK, Uluer A, West NE, Bray LA, Hsu C, Fiastro A, Stukovsky KDH, Hadjiliadis D, Solomon GM, Ladores-Barrett S Contraceptive use and pregnancy in cystic fibrosis: Survey findings from 10 cystic fibrosis centers. , J Cyst Fibros, 1569-1993(25)00006-2: 2025

O'Brien SH, Stanek JR, House A, Cronin RM, Creary SE, Roe AH, Vesely SK Trends in Pregnancy Outcomes in People with Sickle Cell Disease and Medicaid Insurance (2006-2018). , J Womens Health (Larchmt), 34(1):21-26: 2025

Wu JK, McVay K, Mahoney KM, Sayani FA, Roe AH, Cebert M Experiences with healthcare navigation and bias among adult women with sickle cell disease: a qualitative study. , Qual Life Res, 33(12):3459-346: 2024

Chen J, Nijim S, Koelper N, Flynn AN, Sonalkar S, Schreiber CA, Roe AH Telemedicine Follow-up After Medication Management of Early Pregnancy Loss. , J Womens Health (Larchmt), 33(11):1449-1456: 2024

Godfrey EM, Magaret A, Hsu C, Walker P, Langfelder-Schwind E, Roe AH, Uluer A, West NE, Taylor-Cousar JL, Bray LA, Mody S, Kazmerski TM, Jain R, Aitken ML Contraceptive use and pregnancy trends in the era of CFTR modulator therapy: findings from the CASE.4.CF study , North American Cystic Fibrosis Conference: 2024